Macrophages and B cells process antigens to produce antigenic peptides that associate with class II major histocompatibility complex molecules (e.g., Ia molecules); these la-peptide complexes are recognized by CD41 T lym-
phocytes. Processing of the antigen hen egg white lysozyme was inhibited by cycloheximide in peritoneal exudate cells (PECs, largely macrophages), but not in TA3 B-lymphoma cells. The uptake and metabolism of hen egg white lysozyme was largely intact in cycloheximide-treated PECs, implicating a blockade in other steps in the formation of Ia-peptide complexes. Turnover of Ia-peptide complexes was markedly enhanced in viable antigen-presenting cells (TA3 and PEC) as compared to such complexes studied on fixed cells or in isolated preparations of Ia and peptide. In B cells the half-life of la-peptide complexes was much shorter than the half-life of the Ia molecules, implying turnover of Ia-peptide complexes by dissociation and peptide exchange. In PECs, the dissociation of la-peptide complexes was more limited; the enhanced Ia-peptide turnover in viable PECs reflected in part biosynthetic turnover of Ia molecules. Specific mechanisms may exist in TA3 cells to facilitate exchange of peptides bound to Ia, allowing recycling of Ia to present another antigenic peptide; such Ia recycling would explain the ability of these cells to process and present antigen in the absence of Ia synthesis. CD4+ T lymphocytes recognize processed antigen associated with class II major histocompatibility complex (Ia) molecules. Antigen processing involves internalization, denaturation, and proteolysis of antigen, with subsequent binding of antigen-derived peptides to Ia molecules (1) . The site of formation of Ia-peptide complexes remains unclear, but some evidence suggests that these complexes may form within intracellular vesicular compartments (i.e., endosomes). Ta is internalized and sequestered within endosomes (2) , although the necessity of Ia endocytosis for antigen processing is unproven. B-lymphoma cells process antigen in the absence ofprotein synthesis (2) . Thus, newly synthesized Ia is not necessary in these cells. In contrast, protein synthesis inhibitors block antigen processing by adherent peritoneal macrophages (2, 3) .
In vitro studies of peptide binding to isolated Ta molecules demonstrate a Kd of -10-6 M and very slow binding and dissociation kinetics (4) (5) (6) 
METHODS
Cells. The murine B-lymphoma hybridoma TA3 (H-2kxd) (8), the CH-27 B lymphoma (H-2k) (9) , and the 3A9 T-cell hybridoma were maintained in RPMI 1640 medium supplemented with 10% (vol/vol) fetal or newborn calf serum and antibiotics. 3A9 (13) , and the amount of I-A was quantitated by densitometry. Ta-Peptide Binding Assays. Isolated I-Ak was prepared and its interaction with HEL-(46-61), HEL-(52-61), and derivatives of these peptides was studied using methods described in detail elsewhere (6 Despite the presence of an intracellular pool of Ta in suspension PECs, as in TA3 cells, antigen processing by PECs in suspension was inhibited by cycloheximide (Fig. 1) . This inhibition was always observed with PECs, whether adherent or in suspension, but was not observed with TA3 cells, therefore, representing an inherent difference between these cell types not simply related to Ta distribution. Full inhibition of antigen processing in suspension PECs required a 2-to 3-hr preincubation with cycloheximide (10 ,g/ml) before the addition of antigen (Fig. 1) , similar to results obtained with adherent PECs.
To clarify the mechanism of this effect, the influence of cycloheximide on the metabolism of HEL by PECs was investigated. After incubation with cycloheximide (10 ,g/ml) for 3 hr, PECs were exposed to 125T-labeled HEL for 30 min at 37°C, washed, and then incubated in medium for 1-5 hr. The amounts of acid-soluble and acid-insoluble material were determined in the medium and in cell fractions. The total HEL uptake after 30 min was decreased by only 16% in the presence of cycloheximide. The production of intracellular and extracellular trichloroacetic acid-soluble HEL metabolites declined by about 50% in the presence of cycloheximide (data not shown). Fig. 2 shows one representative experiment). In contrast, if these cells were fixed immediately after exposure to the peptide, the Ta-peptide complexes were stably expressed for at least 27 hr. In PECs, expression of Ia-peptide complexes also declined (albeit somewhat more slowly) in viable cells, with a half-life of 5.5 hr (3.4-7.5 hr), but remained stable for at least 69 hr on fixed PECs (Fig. 3) . Similar results were obtained if the PECs were first fixed, washed, then exposed to peptide, washed, and finally incubated at 37°C for various periods; under these conditions Iapeptide complexes were stably expressed for at least 81.5 hr (Fig. 3 molecules in PECs and TA3 cells (Fig. 4) (Fig. 5) (6) . Binding was inhibited by the addition of excess unlabeled peptide (6) . Similar data were obtained with I-Ak isolated from both TA3 and CH-27 cells. Fractions containing the I-Ak-peptide complex were pooled and incubated at room temperature for various periods. Subsequent analysis by Sephadex G-50 column filtration showed that only 1-10% ofbound peptide dissociated over 72 hr at pH 7.3 ( Fig. 5) . At pH 4.5 dissociation was only slightly enhanced; 10-20% of the bound peptide dissociated over a 40-hr period.
DISCUSSION
It is important, in trying to understand the biology of antigen presentation, to determine a number of properties of Ia molecules in viable cells (i.e., their availability and binding properties, cellular distribution, degree of occupancy by self or foreign peptides, turnover rates, etc.). It appears that a significant amount of Ia molecules expressed on the cell surface are already occupied by peptides, either self or foreign, and that only a fraction of them may be available for binding to new peptides. In our recent experiments 1-1o of the isolated Ta molecules could be occupied by HEL at saturation (6) . The Ta molecule has not yet been provided. These data also address the dissociation rate of only a single species of Ia-peptide complex [I-Ak-HEL-(46-61)] and closely related analogs; the turnover rate of different peptides bound to Ta could vary, leading to somewhat different estimates of the rate of Ta recycling. However, the striking differences in Ia-peptide dissociation observed between the PECs and TA3 cells using the same methodology and T-cell hybridoma support a real difference in Ia physiology between these cell types. In addition, these observations clearly imply the existence of active processes in viable antigen-presenting cells that mediate turnover of Ia-peptide complexes, whether by la recycling with peptide exchange (TA3 cells), turnover of la molecules by biosynthesis and degradation, or a combination of both processes (PECs). Therefore, the much slower rates of association and dissociation observed with isolated la and peptide or fixed cells do not apply to the living cell.
The mechanisms involved in facilitating Ia-peptide turnover by peptide exchange are unknown. Peptide exchange might occur within endosomes; in this case the acidic endosomal environment could facilitate Ia-peptide dissociation and exchange, although this is not supported well by our data. Alternatively, specific proteins or other unknown factors in endosomes or elsewhere in the cell may serve to catalyze or facilitate Ia-peptide dissociation and peptide exchange.
